Process for the preparation of a fermented milk product
US-2024373869-A1 · Nov 14, 2024 · US
Antihypertensive peptide probiotic goat milk powder and preparation method thereof
US12564618B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12564618-B2 |
| Application number | US-202519208663-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 15, 2025 |
| Priority date | Jun 7, 2024 |
| Publication date | Mar 3, 2026 |
| Grant date | Mar 3, 2026 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
An antihypertensive peptide probiotic goat milk powder and a preparation method thereof are provided. Goat milk is used as a raw material, the goat milk is sterilized and then cooled, and the screened probiotic bacteria for fermenting goat milk to produce antihypertensive peptides, namely Lacticaseibacillus rhamnosus KD5 (which is preserved in CCTCC on Sep. 7, 2023, with a preservation number of CCTCC NO: M20231641), is added and stirred evenly, and then fermented at a constant temperature. After the fermentation is completed, probiotic fermented goat milk containing antihypertensive peptides is obtained. After mixing the probiotic fermented goat milk evenly with or without nutritional fortifiers for middle-aged and elderly people, it is subjected to vacuum low-temperature spray-drying to obtain antihypertensive peptide probiotic goat milk powder, which has a high ACE inhibition rate and can be used to assist consumers in lowering blood pressure.
First claim
Opening claim text (preview).
What is claimed is: 1 . A method of making an antihypertensive probiotic dairy product, comprising: (1) inoculating 0.01% to 0.05% of lyophilized powder of Lacticaseibacillus rhamnosus KD5 into sterilized and cooled goat milk to obtain a mixture; and (2) fermenting the mixture at a constant temperature of 34° C. to 40° C. for 22 to 26 hours, wherein the Lacticaseibacillus rhamnosus KD5 is preserved at China Center for Type Culture Collection (CCTCC) with a preservation number of CCTCC NO: M20231641, and the antihypertensive probiotic dairy product comprises 16 peptides of amino acid sequences SEQ ID NO: 1-16.
Assignees
Inventors
Classifications
Lactobacilli, e.g. L. acidophilus or L. brevis · CPC title
Milk; Whey; Colostrum · CPC title
characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp. · CPC title
- A23C9/1232Primary
in powdered, granulated or dried solid form · CPC title
Rhamnosus · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12564618B2 cover?
- An antihypertensive peptide probiotic goat milk powder and a preparation method thereof are provided. Goat milk is used as a raw material, the goat milk is sterilized and then cooled, and the screened probiotic bacteria for fermenting goat milk to produce antihypertensive peptides, namely Lacticaseibacillus rhamnosus KD5 (which is preserved in CCTCC on Sep. 7, 2023, with a preservation number…
- Who is the assignee on this patent?
- Univ Shaanxi Science & Tech
- What technology area does this patent fall under?
- Primary CPC classification A23C9/1232. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).